Tamara Madacsy

Ms. Tamara Madacsy

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
PPPetra Pallagi
Petra Pallagi
TMTamara Madacsy
Tamara Madacsy
AVArpad Varga
Arpad Varga
MJMaléth József
Maléth József
Intracellular Ca2+ signalling is a major signal transductional pathway in non-excitable cells, responsible for the regulation of a variety of physiological functions. In the secretory epithelial cells of the exocrine pancreas, such as acinar and ductal cells, intracellular Ca2+ elevation regulates digestive enzyme secretion in acini or fluid and ion secretion in ductal cells. Although Ca2+ is a uniquely versatile orchestrator of epithelial physiology, unregulated global elevation of the intracellular Ca2+ concentration is an early trigger for the development of acute pancreatitis (AP). Regardless of the aetiology, different forms of AP all exhibit sustained intracellular Ca2+ elevation as a common hallmark. The release of endoplasmic reticulum (ER) Ca2+ stores by toxins (such as bile acids or fatty acid ethyl esters (FAEEs)) or increased intrapancreatic pressure activates the influx of extracellular Ca2+ via the Orai1 Ca2+ channel, a process known as store-operated Ca2+ entry (SOCE). Intracellular Ca2+ overload can lead to premature activation of trypsinogen in pancreatic acinar cells and impaired fluid and HCO3- secretion in ductal cells. Increased and unbalanced reactive oxygen species (ROS) production caused by sustained Ca2+ elevation further contributes to cell dysfunction, leading to mitochondrial damage and cell death. Translational studies of AP identified several potential target molecules that can be modified to prevent intracellular Ca2+ overload. One of the most promising drugs, a selective inhibitor of the Orai1 channel that has been shown to inhibit extracellular Ca2+ influx and protect cells from injury, is currently being tested in clinical trials. In this review, we will summarise the recent advances in the field, with a special focus on the translational aspects of the basic findings.

Verified
Journal Article
Open access
PDF file
EBEdina Bakondi
Edina Bakondi
SSSalam Bhopen Singh
Salam Bhopen Singh
ZHZoltán Hajnády
Zoltán Hajnády
MNMáté Nagy-Pénzes
Máté Nagy-Pénzes
ZRZsolt Regdon
Zsolt Regdon
László VirágLászló Virág
László Virág
Activated macrophages upregulate inducible nitric oxide synthase (iNOS) leading to the profuse production of nitric oxide (NO) and, eventually, tissue damage. Using macrophage NO production as a biochemical marker of inflammation, we tested different parts (flower, leaf, and stem) of the medicinal plant, Spilanthes acmella. We found that extracts prepared from all three parts, especially the flowers, suppressed NO production in RAW macrophages in response to interferon-γ and lipopolysaccharide. Follow up experiments with selected bioactive molecules from the plant (α-amyrin, β-caryophylline, scopoletin, vanillic acid, trans-ferulic acid, and spilanthol) indicated that the N-alkamide, spilanthol, is responsible for the NO-suppressive effects and provides protection from NO-dependent cell death. Spilanthol reduced the expression of iNOS mRNA and protein and, as a possible underlying mechanism, inhibited the activation of several transcription factors (NFκB, ATF4, FOXO1, IRF1, ETS, and AP1) and sensitized cells to downregulation of Smad (TF array experiments). The iNOS inhibitory effect translated into an anti-inflammatory effect, as demonstrated in a phorbol 12-myristate 13-acetate-induced dermatitis and, to a smaller extent, in cerulein-induced pancreatitis. In summary, we demonstrate that spilanthol inhibits iNOS expression, NO production and suppresses inflammatory TFs. These events likely contribute to the observed anti-inflammatory actions of spilanthol in dermatitis and pancreatitis.

28 October 2020 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
ABAnita Bálint
Anita Bálint
KFKlaudia Farkas
Klaudia Farkas
OMOrsolya Méhi
Orsolya Méhi
BKBálint Kintses
Bálint Kintses
BVBálint Márk Vásárhelyi
Bálint Márk Vásárhelyi
TMTamás Molnár
Tamás Molnár
Gut microbial composition alters in some special situations, such as in ulcerative colits (UC) after total proctocolectomy and ileal pouch-anal anastomosis (IPAA) surgery. The aim of our study was to determine the composition of the intestinal microbiome in UC patients after IPAA surgery, compared with UC patients, familial adenomatous polyposis (FAP) patients after IPAA surgery and healthy controls. Clinical data of patients, blood and faecal samples were collected. Faecal microbiota structure was determined by sequencing the V4 hypervariable region of the 16S rRNA gene. Overall, 56 patients were enrolled. Compared to the Healthy group, both the Pouch active and UC active groups had higher Enterobacteriaceae, Enterococcaceae and Pasteurellaceae abundance. The Pouch and UC groups showed distinct separation based on their alpha and beta bacterial diversities. The UC group had higher Prevotellaceae, Rikenellaceae, Ruminococcaceae abundance compared to the Pouch active group. Pouch and FAP participants showed similar bacterial community composition. There was no significant difference in the bacterial abundance between the active and inactive subgroups of the Pouch or UC groups. Gut microbiome and anatomical status together construct a functional unit that has influence on diversity, in addition to intestinal inflammation that is a part of the pathomechanism in UC.

17 August 2022
Verified
Thesis
Closed access
TMTamara Madacsy
Tamara Madacsy
Háttér és célok. Az alkoholos hasnyálmirigy- és májgyulladás gyakori, potenciálisan halálos kimenetelű betegség, korlátozott terápiás lehetőségekkel. Egy korábbi tanulmányunk arról számolt be, hogy a CFTR Cl- csatorna expresszióját az etanol károsítja a hasnyálmirigy duktális epitél sejtjeiben, ami súlyos alkohol-indukált pankreatítiszhez vezet. Az epiteliális ionszekréció meghatározásán túl a CFTR-nek számos kölcsönhatása van más fehérjékkel, amelyek befolyásolhatják az intracelluláris Ca2+ jelátvitelt. Ezért célul tűztük ki, hogy megvizsgáljuk az etanol által kiváltott CFTR-károsodás hatását az intracelluláris Ca2+ homeosztázisra a hasnyálmirigy duktális epitélsejtjeiben és cholangiocitákban. Módszerek. Humán és egér hasnyálmirigy- és máj mintákat, valamint ex vivo organoidokat használtunk az ionszekréció, az intracelluláris jelátvitel, valamint a fehérjék expressziójának és kölcsönhatásának vizsgálatára. A PMCA4 gátlás hatását az alkohol által kiváltott hasnyálmirigy-gyulladás egér modelljében elemeztük. Eredmények. A csökkent CFTR-expresszió károsította a PMCA működését, és tartós intracelluláris Ca2+ emelkedést eredményezett etanollal kezelt, valamint egér és humán hasnyálmirigy organoidokban. Az alkoholos hepatítiszes betegekből származó májminták és az etanollal kezelt egér máj organoidok csökkent CFTR-expressziót és -funkciót, valamint károsodott PMCA4-aktivitást mutattak. A PMCA4 kolokalizálódik és fizikai kölcsönhatásba lép a CFTR-rel a polarizált epitélsejtek apikális membránján, ahol a CFTR-függő kalmodulin rekrutáció határozza meg a PMCA4 aktivitását. A tartós intracelluláris Ca2+ emelkedés CFTR hiányában gátolta a mitokondriális funkciót és fokozott apoptózissal járt együtt a hasnyálmirigy epitélsejtekben, a PMCA4 gátlása pedig növelte az alkohol okozta AP súlyosságát egerekben. Következtetés. Eredményeink arra utalnak, hogy a Ca2+ -extrúzió javítása az epitélsejtekben potenciális új terápiás megközelítés lehet az exokrin hasnyálmirigy-funkció védelmére alkoholos pankreatítiszben és az alkoholos hepatítiszben kialakuló cholestasis megelőzésére.


15 January 2020 in Journal of Crohn's and Colitis
Verified
Journal Article
Open access
PDF file
PBPéter Bacsur 
Péter Bacsur 
KSKata Szántó
Kata Szántó
TMTamara Madacsy
Tamara Madacsy
DKDiana Kata
Diana Kata
TFT Ferenci
T Ferenci
TMTamás Molnár
Tamás Molnár
Anti-tumour necrosis factor (TNF) therapy has dramatically changed the treatment of inflammatory bowel disease (IBD). The relationship between clinical outcomes and serum anti-TNF levels is controversial. This study aimed to perform simultaneous analyses of the serum, mucosal and faecal infliximab and adalimumab levels to determine the mucosal expression of TNF-α and assess the relationship of the anti-TNF-α levels in these biological samples with the endoscopic and clinical activities and body composition in IBD patients. Consecutive IBD patients who received maintenance anti-TNF-α therapy and underwent colonoscopy were enrolled. We assessed the clinical disease activity, collected the blood, faecal and biopsy samples. The number of TNF-α positive cells in the mucosa was detected using immunofluorescent labelling. Serum, mucosal and faecal anti-TNF-α levels, anti-drug antibody level in the serum and faecal calprotectin were determined using ELISA. Each patient underwent body composition analysis. Fifty consecutive patients have been analysed in the study. The number TNF-α positive cells was significantly higher in the inflamed than in the un-inflamed part of the colon (p = 0.01); however, such a difference was not detected in case of tissue drug levels. Tissue drug level did not correlate with the serum drug level. Nevertheless, tissue drug levels of the samples obtained from the un-inflamed part of the colon were significantly higher in patients who were in remission (p = 0.03467). The presence of the drug in the faeces was significantly different according to disease activity (p = 0.0022). Drug levels in the biological samples did not show any association with the presence of anti-drug antibodies. Body composition parameters had no significant impact on the serum and tissue drug levels. Faecal calprotectin showed significant correlation with faecal drug concentration (p = 0.0162) and clinical and endoscopic activity (p < 0.001). To the best our knowledge, this is the first study to measure drug concentrations in all the relevant biological samples. Our findings highlight the importance of faecal drug monitoring because active disease may be present in spite of normal serum anti-TNF levels. Simultaneous determination of faecal drug concentration and faecal calprotectin may be more accurate for evaluating therapeutic responses in the future.